← Patent-cliff monitor small molecule MIPLYFFA ARIMOCLOMOL CITRATE
Loss of exclusivity November 2041 latest FDA-listed patent expiry
Company ZEVRA DENMARK AS
Drug detail Brand name MIPLYFFA Active ingredient ARIMOCLOMOL CITRATE Strength EQ 124MG BASE Dosage form CAPSULE Route ORAL Modality Small molecule FDA approval September 2024 Marketing status RX
Listed patents Patent Expires Type 11707456 November 2041 substance, product 11045460 August 2029 use U-4021 9289472 August 2029 use U-4021 9884058 June 2029 use U-4021
Regulatory exclusivity Code Expires ODE-496 September 2031 NCE September 2029
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.